Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | TAR-binding protein | 0.0131 | 0.8334 | 0.8334 |
Loa Loa (eye worm) | hypothetical protein | 0.0155 | 1 | 1 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0028 | 0.1056 | 0.0928 |
Echinococcus multilocularis | lamin dm0 | 0.0028 | 0.1056 | 0.1023 |
Schistosoma mansoni | intermediate filament proteins | 0.0028 | 0.1056 | 0.0757 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0037 | 0.1709 | 0.1679 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0019 | 0.0459 | 0.5 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0019 | 0.0459 | 0.0323 |
Echinococcus granulosus | lamin | 0.0028 | 0.1056 | 0.1023 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0019 | 0.0459 | 0.5 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0019 | 0.0459 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0024 | 0.0794 | 0.2675 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0015 | 0.0141 | 0.0141 |
Treponema pallidum | 4'-phosphopantetheinyl transferase | 0.0024 | 0.0794 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0131 | 0.8334 | 1 |
Brugia malayi | hypothetical protein | 0.0037 | 0.1709 | 0.1591 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0019 | 0.0459 | 0.0425 |
Echinococcus granulosus | L aminoadipate semialdehyde | 0.0086 | 0.516 | 0.5143 |
Schistosoma mansoni | hypothetical protein | 0.0037 | 0.1709 | 0.1587 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0028 | 0.1056 | 0.1056 |
Wolbachia endosymbiont of Brugia malayi | 4'-phosphopantetheinyl transferase | 0.0024 | 0.0794 | 1 |
Schistosoma mansoni | aminoadipate-semialdehyde dehydrogenase | 0.0086 | 0.516 | 0.5969 |
Mycobacterium leprae | conserved hypothetical protein | 0.0024 | 0.0794 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.1056 | 0.1056 |
Echinococcus multilocularis | muscleblind protein | 0.0155 | 1 | 1 |
Echinococcus multilocularis | lamin | 0.0028 | 0.1056 | 0.1023 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.102 | 0.102 |
Schistosoma mansoni | lamin | 0.0028 | 0.1056 | 0.0757 |
Loa Loa (eye worm) | RNA binding protein | 0.0131 | 0.8334 | 0.8334 |
Mycobacterium ulcerans | phosphopantetheinyl transferase, PptII | 0.0024 | 0.0794 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0013 | 0.0036 | 0.0036 |
Mycobacterium ulcerans | 4'-phosphopantetheinyl transferase | 0.0024 | 0.0794 | 1 |
Leishmania major | phosphopantetheinyl transferase-like protein | 0.0024 | 0.0794 | 1 |
Brugia malayi | RNA binding protein | 0.0131 | 0.8334 | 0.8311 |
Toxoplasma gondii | 4'-phosphopantetheinyl transferase domain-containing protein | 0.0024 | 0.0794 | 1 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0155 | 1 | 1 |
Brugia malayi | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | 0.0086 | 0.516 | 0.5091 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0131 | 0.8334 | 0.8334 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.1709 | 1 |
Brugia malayi | TAR-binding protein | 0.0131 | 0.8334 | 0.8311 |
Echinococcus multilocularis | L aminoadipate semialdehyde | 0.0086 | 0.516 | 0.5143 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0024 | 0.0794 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.1709 | 1 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0037 | 0.1709 | 0.1587 |
Echinococcus granulosus | tar DNA binding protein | 0.0131 | 0.8334 | 0.8328 |
Schistosoma mansoni | tar DNA-binding protein | 0.0131 | 0.8334 | 1 |
Echinococcus granulosus | intermediate filament protein | 0.0028 | 0.1056 | 0.1023 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0019 | 0.0459 | 0.5 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0037 | 0.1709 | 0.1679 |
Echinococcus granulosus | lamin dm0 | 0.0028 | 0.1056 | 0.1023 |
Plasmodium falciparum | holo-[acyl-carrier-protein] synthase, putative | 0.0024 | 0.0794 | 1 |
Toxoplasma gondii | 4'-phosphopantetheinyl transferase superfamily protein | 0.0024 | 0.0794 | 1 |
Chlamydia trachomatis | holo [acyl-carrier protein] synthase | 0.0024 | 0.0794 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.1709 | 1 |
Onchocerca volvulus | 0.0086 | 0.516 | 1 | |
Echinococcus granulosus | muscleblind protein | 0.0155 | 1 | 1 |
Echinococcus multilocularis | musashi | 0.0028 | 0.1056 | 0.1023 |
Schistosoma mansoni | tar DNA-binding protein | 0.0131 | 0.8334 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0131 | 0.8334 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.1709 | 1 |
Brugia malayi | intermediate filament protein | 0.0028 | 0.1056 | 0.0928 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0019 | 0.0459 | 0.5 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0019 | 0.0459 | 0.0425 |
Loa Loa (eye worm) | hypothetical protein | 0.0155 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0131 | 0.8334 | 1 |
Loa Loa (eye worm) | intermediate filament protein | 0.0028 | 0.1056 | 0.1056 |
Plasmodium vivax | holo-[acyl-carrier-protein] synthase, putative | 0.0024 | 0.0794 | 1 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0019 | 0.0459 | 0.0459 |
Mycobacterium tuberculosis | holo-[acyl-carrier protein] synthase AcpS (holo-ACP synthase) (CoA:APO-[ACP]pantetheinephosphotransferase) (CoA:APO-[acyl-carrie | 0.0024 | 0.0794 | 1 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0131 | 0.8334 | 0.8311 |
Echinococcus multilocularis | tar DNA binding protein | 0.0131 | 0.8334 | 0.8328 |
Loa Loa (eye worm) | hypothetical protein | 0.0086 | 0.516 | 0.516 |
Schistosoma mansoni | lamin | 0.0028 | 0.1056 | 0.0757 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.